XML 54 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity Plans (Tables)
12 Months Ended
Dec. 31, 2017
Schedule of activity under equity incentive plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

 

 

 

 

 

Weighted-

 

Weighted-

 

 

 

 

 

 

 

 

Average

 

Average

 

 

 

 

Options

 

 

 

Exercise

 

Remaining

 

Aggregate

 

 

Available for

 

Options

 

Price Per

 

Contractual

 

Intrinsic

 

    

Grant

    

Outstanding

    

Share

    

Life (years)

    

Value (1)

 

 

 

 

 

 

 

 

 

 

 

(in millions)

Balances at December 31, 2014

 

116,832

  

476,006

  

$

1.40

 

8.04

 

 

  

Additional options authorized

 

431,411

  

 

 

  

 

  

 

 

  

Options granted

 

(408,623)

  

408,623

  

 

1.24

 

  

 

 

  

Options exercised

 

 

(43,852)

 

 

1.30

  

 

  

 

 

Options forfeited

 

7,599

  

(7,599)

  

 

1.40

 

  

 

 

  

Balances at December 31, 2015

 

147,219

  

833,178

  

 

1.33

 

8.56

 

 

  

Additional options authorized

 

1,697,088

  

 

 

  

 

  

 

 

  

Options granted

 

(1,679,979)

  

1,679,979

  

 

14.24

 

  

 

 

  

Options exercised

 

 

(119,328)

 

 

1.28

  

 

  

 

 

Balances at December 31, 2016

 

164,328

  

2,393,829

  

 

10.39

 

8.79

 

 

  

Additional options authorized

 

668,891

  

 

 

 

 

  

 

 

  

Options granted

 

(493,500)

  

493,500

  

 

13.20

 

  

 

 

  

Options exercised

 

 

(257,858)

 

 

1.84

  

 

  

 

 

Options forfeited

 

191,320

 

(191,320)

 

 

15.00

 

 

 

 

 

Balances at December 31, 2017

 

531,039

  

2,438,151

  

$

11.51

 

8.26

 

$

23.3

Options exercisable – December 31, 2017

 

 

  

877,888

  

$

9.70

 

7.61

 

$

10.0

Options vested and expected to vest – December 31, 2017

 

 

  

2,438,151

 

$

11.51

 

8.26

 

$

23.3

____________________

(1) The aggregate intrinsic values were calculated as the difference between the exercise price of the options and the closing price of the Company’s common stock on December 31, 2017. The calculation excludes options with an exercise price higher than the closing price of the Company’s common stock on December 31, 2017.

 

Schedule of stock-based compensation expense

Total stock-based compensation expense was as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

    

2017

    

2016

    

2015

Research and development

 

$

2,008

 

$

1,080

 

$

39

General and administrative

 

 

2,233

 

 

1,050

 

 

60

Total stock-based compensation expense

 

$

4,241

 

$

2,130

 

$

99

 

Employee stock options  
Schedule of valuation assumptions

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

 

    

2017

    

2016

 

2015

 

Expected term (in years)

 

5.50 – 6.08

 

4.16 – 5.95

 

5.89

 

Expected volatility

 

61.6% – 65.4%

 

62.5% – 64.8%

 

59.8%

 

Risk-free interest rate

 

1.88% – 2.24%

  

1.27% – 1.79%

  

1.57% – 1.58%

 

Dividend yield

 

 

 

 

 

Non-employee stock options  
Schedule of valuation assumptions

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

 

    

2017

    

2016

    

2015

 

Expected term (in years)

 

6.97 – 7.40

 

6.59 – 9.97

  

6.80

  

Expected volatility

 

61.7% – 65.4%

 

62.5% – 62.8%

 

59.8%

 

Risk-free interest rate

 

2.17% – 2.33%

 

1.29% – 1.79%

 

1.95%

 

Dividend yield

 

 

 —

  

—   

 

 

ESPP rights  
Schedule of valuation assumptions

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

 

 

2017

    

 

2016

 

Expected term (in years)

 

0.50

 

 

0.60

 

Expected volatility

 

52.43% – 52.44%

 

 

52.48%

 

Risk-free interest rate

 

0.89% – 1.16%

 

 

0.45%

 

Dividend yield

 

 —

 

 

 —